Dynamic DNA methylation change in the CpG island region of p15 during human myeloid development

被引:34
作者
Sakashita, K
Koike, K
Kinoshita, T
Shiohara, M
Kamijo, T
Taniguchi, S
Kubota, T
机构
[1] Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano 3908621, Japan
[2] Shinshu Univ, Sch Med, Inst Organ Transplants Reconstruct Med & Tissue E, Matsumoto, Nagano 3908621, Japan
[3] Shinshu Univ, Sch Med, Dept Mol Oncol & Angiol, Res Ctr Aging & Adaptat, Matsumoto, Nagano 3908621, Japan
[4] Shinshu Univ, Sch Med, Dept Clin & Mol Genet, Matsumoto, Nagano 3908621, Japan
关键词
D O I
10.1172/JCI200113030
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We examined the kenetics of p15 methylation and expression during myeloid development. We treated human cord blood CD34(+) cells with either GM-CSF alone or in combination with stem cell factor and followed methylation at this locus using bisulfite genomic sequencing. CD34(+) cells were found to be either fully methylated or completely unmethylated at 27 CpG dinucleotide sites in exon 1 and at 18 CpG sites in the promoter region of the p15 gene. A time-course study showed that the percentage of the allelic methylation of p15 CpG island increased to approximately 50% to 60% until 7 days after cytokine stimulation, then decreased to less than 10% after 21 days. The methylation was also observed in bone marrow CD34(+) cells exposed to GM-CSF. p15 expression varied inversely with methylation. Expression was negligible or at low levels until 14 days, after which it increased substantially. The frequency of myeloid colony-forming cells in the progeny decreased and myeloid-specific markers increased in the later stages. Based on our observations on cells grown with GM-CSF and 5-aza-2'-deoxtcytidine, DNA methylation of the p15 promoter region CpG island appears to be associated with proliferation rather than differentiation of normal human myeloid progenitors.
引用
收藏
页码:1195 / 1204
页数:10
相关论文
共 27 条
[21]   Apoptosis of erythroid precursors under stimulation with thrombopoietin: Contribution to megakaryocytic lineage choice [J].
Sawai, N ;
Koike, K ;
Ito, S ;
Kurokawa, Y ;
Mwamtemi, HH ;
Kinoshita, T ;
Sakashita, K ;
Higuchi, T ;
Takeuchi, K ;
Shiohara, M ;
Ogami, K ;
Komiyama, A .
STEM CELLS, 1999, 17 (01) :45-53
[22]   Expression and regulation of G(1) cell-cycle inhibitors (p16(INK4A), p15(INK4B), p18(INK4C), p19(INK4D)) in human acute myeloid leukemia and normal myeloid cells [J].
Schwaller, J ;
Pabst, T ;
Koeffler, HP ;
Niklaus, G ;
Loetscher, P ;
Fey, MF ;
Tobler, A .
LEUKEMIA, 1997, 11 (01) :54-63
[23]   A NEW REGULATORY MOTIF IN CELL-CYCLE CONTROL CAUSING SPECIFIC-INHIBITION OF CYCLIN-D/CDK4 [J].
SERRANO, M ;
HANNON, GJ ;
BEACH, D .
NATURE, 1993, 366 (6456) :704-707
[24]   DNA methylation [J].
Singal, R ;
Ginder, GD .
BLOOD, 1999, 93 (12) :4059-4070
[25]   Hypermethylation of the p15(INK4B) gene in myelodysplastic syndromes [J].
Uchida, T ;
Kinoshita, T ;
Nagai, H ;
Nakahara, Y ;
Saito, H ;
Hotta, T ;
Murate, T .
BLOOD, 1997, 90 (04) :1403-1409
[26]  
Wong DJ, 1999, MOL CELL BIOL, V19, P5642
[27]   CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis [J].
Zupo, S ;
Isnardi, L ;
Megna, M ;
Massara, R ;
Malavasi, F ;
Dono, M ;
Cosulich, E ;
Ferrarini, M .
BLOOD, 1996, 88 (04) :1365-1374